Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
Clinical trial NCT00295594 · COMPLETED
Trial details
- NCT number
- NCT00295594
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2007-06-01
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.